ANGELA PIERCE: Open Payments
NPI 1467822270 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 28 payments from 8 companies in 2025. Trend: 2023 $791 · 2024 $532 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $246 |
| Exact Sciences Corporation | 4 | $103 |
| Lilly USA, LLC | 4 | $86 |
| Abbott Laboratories | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Agios Pharmaceuticals, Inc. | 1 | $36 |
| ABBVIE INC. | 1 | $22 |
| PFIZER INC. | 1 | $18 |
Products named: Ozempic, FREESTYLE LIBRE 3, MOUNJARO, Wegovy, Rybelsus, PYRUKYND, The Cologuard Plus Collection Kit, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
